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Background: Mycoplasma gallisepticum is a major poultry pathogen and causes severe economic loss to the
poultry industry. In mycoplasmas lipoproteins are abundant on the membrane surface and play a critical role in
interactions with the host, but tools for exploring their molecular biology are limited.
Results: In this study we examined whether the alkaline phosphatase gene (phoA) from Escherichia coli could be
used as a reporter in mycoplasmas. The promoter region from the gene for elongation factor Tu (ltuf ) and the
signal and acylation sequences from the vlhA1.1 gene, both from Mycoplasma gallisepticum, together with the
coding region of phoA, were assembled in the transposon-containing plasmid pISM2062.2 (pTAP) to enable
expression of alkaline phosphatase (AP) as a recombinant lipoprotein. The transposon was used to transform
M. gallisepticum strain S6. As a control, a plasmid containing a similar construct, but lacking the signal and acylation
sequences, was also produced (pTP) and also introduced into M. gallisepticum. Using a colorimetric substrate for
detection of alkaline phosphatase activity, it was possible to detect transformed M. gallisepticum. The level of
transcription of phoA in organisms transformed with pTP was lower than in those transformed with pTAP, and
alkaline phosphatase was not detected by immunoblotting or enzymatic assays in pTP transformants, eventhough
alkaline phosphatase expression could be readily detected by both assays in pTAP transformants. Alkaline
phosphatase was shown to be located in the hydrophobic fraction of transformed mycoplasmas following Triton
X-114 partitioning and in the membrane fraction after differential fractionation. Trypsin proteolysis confirmed its
surface exposure. The inclusion of the VlhA lipoprotein signal sequence in pTAP enabled translocation of PhoA and
acylation of the amino terminal cysteine moiety, as confirmed by the effect of treatment with globomycin and
radiolabelling studies with [14 C]palmitate. PhoA could be identified by mass-spectrometry after separation by two-
dimensional electrophoresis.
Conclusion: This is the first study to express PhoA as a lipoprotein in mycoplasmas. The pTAP plasmid will facilitate
investigations of lipoproteins and protein translocation across the cell membrane in mycoplasmas, and the ease of
detection of these transformants makes this vector system suitable for the simultaneous screening and detection of
cloned genes expressed as membrane proteins in mycoplasmas.
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Mycoplasmas are prokaryotes in the class Mollicutes and
are characterised by the absence of a cell wall [1]. Myco-
plasmas cause disease in a number of animal species and
are able to survive and persist in the face of host
defences, even though they possess a relatively small
genome and are bounded by a single protective plasma
membrane. The recent chemical synthesis and cloning
of whole mycoplasma genomes has also drawn attention
to the possibility of creating synthetic cells and genetic
manipulation of the smallest bacterial genomes [2,3].
The proteins within the single limiting membrane of
mycoplasmas fulfill many of the critical functions related
to morphology, nutrient transport, environmental adap-
tation and colonisation of the host [4].
Many of the surface proteins of mycoplasmas are
amphiphilic and/or lipid modified and some have been
shown to be components of solute transport systems or
involved in antigenic variation and adherence, while the
functions of many others remain unknown [5-7]. Myco-
plasmas possess an unusually large number of lipopro-
teins, which are anchored to the cell membrane by a
lipid moiety, with the polypeptide moiety exposed on
the cell’s outer surface [8]. Lipoprotein signal peptides
are cleaved by signal peptidase II at a conserved motif
preceding the amino terminal cysteine of the mature
lipoprotein. The significance of mycoplasma lipoproteins
in interactions with the host emphasises the need to bet-
ter understand how they are processed, and the mechan-
isms controlling their expression [4].
Mycoplasma gallisepticum is a major poultry patho-
gen, causing chronic respiratory disease in chickens, in-
fectious sinusitis in turkeys and conjunctivitis in house
finches [9,10]. It has a worldwide distribution and causes
severe economic losses in the poultry industry. Vaccin-
ation of the flock is a necessity to control mycoplasmosis
in commercial poultry farms. The live vaccines in use at
present are F strain, 6/85 and ts-11 [11]. Although ef-
fective and widely used at present, these vaccines could
be modified to act as vaccine vectors to deliver other
antigens and thus be the basis of multivalent vaccines.
Although the genome of M. gallisepticum strain Rlow
has been sequenced [12], the lack of genetic systems for
mycoplasmas in general impedes our ability to study
their molecular biology. The use of UGA as a trypto-
phan codon in mycoplasmas also makes it tedious to use
heterologous hosts such as Escherichia coli for expres-
sion and characterisation of cloned mycoplasma
sequences [13]. Molecular tools such as reporter gene
systems suitable for studying lipoprotein processing and
expression in mycoplasmas are necessary.
The E. coli ß-galactosidase gene (lacZ) has been used
to identify gene promoters and detect genetic regulatory
elements in M. gallisepticum and Acholeplasma species[14,15], and as a reporter gene in combination with the
vlhA 1.1 promoter in M. gallisepticum S6 [16]. A major
drawback of the use of ß-galactosidase (ß-Gal) as a re-
porter is its limited ability to pass through the bacterial
cytoplasmic membrane [17]. When the gene for an
exported protein is fused to lacZ, the hybrid protein is
membrane bound and such proteins have very low ß-
galactosidase activity [18]. Green fluorescent protein
(GFP) has been used to identify promoter sequences in
DNA libraries of Mycoplasma pneumoniae and Myco-
plasma genitalium in E. coli [19], but GFP could not be
detected following transformation in M. gallisepticum
[20]. The chloramphenicol acetyl transferase (CAT) gene
has also been used as a selectable marker in M. pneumo-
niae using a modified Tn4001 transposon [21].
The phoA gene codes for the E. coli periplasmic alka-
line phosphatase (AP), and is active when exported
across the cytoplasmic membrane into the periplasmic
space [22-24]. Functional alkaline phosphatase is a dimer
of two identical subunits and each subunit contains two
intramolecular disulfide bridges. The amino-terminal
signal sequence is cleaved upon translocation across the
cytoplasmic membrane, and the mature PhoA is folded
into an active conformation after export to the periplas-
mic space. Disulfide bond formation is followed by fold-
ing into monomers and then conversion to the active
dimer conformation [25]. Enzymatic activity of PhoA fu-
sion proteins depends on the presence of an export se-
quence and this principle has been used in developing
reporter vectors to determine membrane protein top-
ology and to facilitate identification of genes involved in
bacterial virulence [26].
The aim of this study was to evaluate whether the E.
coli phoA gene was suitable for use as a reporter gene to
investigate gene expression and protein processing in
mycoplasmas, using a construct incorporating signal
sequences from the M. gallisepticum VlhA1.1 lipopro-
tein and the ltuf promoter to express PhoA as a
membrane-associated lipoprotein.
Results
Construction of plasmid ltufacyphoA (pTAP)
The elongation factor Tu promoter region of 277 bp
(ltuf ) (GenBank accession: X16462) and the leader se-
quence of the vlhA1.1 gene (GenBank accession:
U90714) from M. gallisepticum were originally amplified
by PCR from the genomic DNA of M. gallisepticum
strain S6 and ligated into the pISM2062.2lac [14] vector
to produce the ltufsiglac construct [20]. The ltuf pro-
moter region was amplified from M. gallisepticum gen-
omic DNA by PCR using the LNF and TSR
oligonucleotide primers (Table 1), and the vlhA export
signal sequence of 51 bp was amplified from M. gallisep-
ticum genomic DNA using the TSF and LBR primers
Table 1 Oligonucleotides used in this study





















Lower case indicates changes made to introduce restriction endonuclease cleavage sites and bold lettering indicates the stop codons.
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lap extension PCR using the primers LNF and LBR. The
resultant PCR product was ligated into pGEM-T (Pro-
mega) following the manufacturer’s instructions. The ltuf
promoter and vlhA export signal sequence (ltufsig) re-
gion was excised from pGEM-T by digestion with NotI
and BamHI and ligated into similarly digested
pISM2062.2lac to generate pISM2062.2ltufsiglac. Diges-
tion of pISM2062.2lac with NotI and BamHI resulted in
the loss of one inverted repeat region (IR) in the inser-
tion sequence of the transposon.
The ltuf promoter and the vlhA1.1 signal sequence
from pISM2062.2ltufsiglac were amplified by PCR and
used to create the ltufacyphoA construct. The ltuf pro-
moter, vlhA1.1 signal and acylation sequence were amp-
lified from pISM2062.2ltufsiglac as a single 369 bp
product using the primers LTNF and SBR (Table 1). The
NotI cleavage site was included in the LTNF primer and
the vlhA signal sequence for lipoprotein export and acyl-
ation was included in the SBR primer. The phoA gene
(1335 bp) was amplified from the plasmid pVM01::
TnphoA [27] using the primers AXPF and PBgR
(Table 1). TnphoA encodes alkaline phosphatase without
the export signal sequence and first five amino acids of
the mature protein [24,28]. The 369 bp and 1335 bp
PCR products were joined using overlap extension
PCR to produce a 1693 bp product using the LTNF
and PBgR primers (Figure 1A). The 1693 bp fragmentwas purified from a 1 % agarose gel after electrophor-
esis using the Qiaex gel extraction kit (Qiagen) and
ligated into pGEM-T following the manufacturer’s
instructions. An E. coli transformant containing a plas-
mid of the expected size was selected and the insert
DNA sequence confirmed using BigDye terminator
v3.1 cycle sequencing (Perkin Elmer Applied Biosys-
tems) and the M13 universal primer sites of the vec-
tor. The DNA insert was released from the pGEM-T
vector by digestion with NotI and BglII, gel purified
using the Qiaex gel extraction kit (Qiagen) and ligated
into NotI and BamHI digested pISM2062.2lac [14],
resulting in pISM2062.2ltufacyphoA.
The first 26 bp of the IS256 element, the IR region
that was deleted during NotI-BamHI digestion of the
pISM2062.2 vector, was restored by inserting a 40 bp
double stranded linker oligonucleotide, produced by
annealing IRF and IRR, into the NotI cleavage site of the
construct. The linker IRF oligonucleotide contained a
mutation at the sixth base (C to G) from the 5' end to
inactivate the NotI cleavage site, and included an NheI
cleavage site at the 3' end. IRF and the complementary
IRR oligonucleotide were annealed by mixing them at
equimolar ratios and heating to 50 °C for 1 min, then
slowly cooling at 1 °C/min to 10 °C. The double
stranded linker had 4 base 5' overhangs at each end to
facilitate ligation to NotI digested pISM2062.2ltufacy-
phoA, resulting in NheI and NotI cleavage sites, and
Table 2 Site of integration of transposon in
M. gallisepticum transformants
Transformant Gene insertion site Gene annotation
TAP 3 MGA_0584 Hypothetical protein
TAP 4 MGA_0519 Csn1 family CRISPR-associated
protein
TAP 9 MGA_0906 Subtilisin-like serine protease
TP 1 MGA_0552 Hypothetical protein
TP 4 MGA_0554 Hypothetical protein
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Figure 1 Schematic representation of phoA constructs. A. The different sections, including the ltuf promoter, the signal sequence, the
acylation sequence and the phoA gene, were combined by overlap extension PCR as described in the text and ligated between the NotI and
BamHI sites in pISM2062.2. The site of the IR oligonucleotide linker is shown. The positions of the oligonucleotide primers (Table 1) are also
shown. B. The construct produced containing only the ltuf promoter and phoA gene. IRL: inverted repeat oligonucleotide linker, N: NotI cleavage
site, B: BamHI cleavage site, ATG: translational start codon.
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the modified IR region.
Construction of plasmid ltufphoA (pTP)
The pISM2062.2ltufphoA vector (pTP), which did not
contain either the vlhA1.1 signal sequence or the acyl-
ation sequence of the pTAP plasmid, was also generated.
The LTNF and LTPR primers were used to amplify the
305 bp ltuf promoter region, whilst the phoA gene was
amplified using primers LTPF and PBaR. The PCR pro-
ducts were purified and joined by overlap extension PCR
using primers LTNF and PBaR, which included NotI and
BamHI sites, respectively (Figure 1B). The resultant PCR
product of 1640 bp was gel purified, ligated into pGEM-
T and the DNA sequence confirmed as described above.
The ltufphoA was released from pGEM-T and ligated to
similarly digested pISM2062.2lac, resulting in the plas-
mid pTP, and the IR oligo adaptor then inserted into the
NotI cleavage site as described above.
Transformation of M. gallisepticum with alkaline
phosphatase expression constructs and detection of
transformants
Both pTP and pTAP plasmids were used to transform
M. gallisepticum cells by electroporation. Transformant
colonies were observed on MA plates containing genta-
micin within 4 days, and colonies picked and grown in
MB with gentamicin added. The presence of the genta-
micin gene was confirmed by the amplification of a
223 bp PCR product using the oligonucleotide primers
GmF and GmR. The genomic location of the transposon
in each of the mycoplasma transformants was predicted
following genomic DNA sequencing and BLAST search-
ing the M. gallisepticum Rlow genome (Table 2).The M. gallisepticum-pTAP transformant colonies on
MA plates stained blue following addition of the sub-
strate BCIP/NBT. A strong blue colour development in
10 min was found to indicate transformant colonies,
whilst a light blue colour was observed in untransformed
colonies only after prolonged incubation. The level of
differential staining readily identified pTAP-transformed
mycoplasma colonies and those colonies that were larger
in size and stained a darker blue colour were selected
for subculture and further studies.Quantitative RT-PCR
The levels of phoA mRNA in both pTP and pTAP trans-
formants were normalised to GAPDH gene expression
and the relative abundance determined in three transfor-
mants produced using each construct. The difference in
gene expression relative to GAPDH mRNA in each
transformant was determined. The average level of tran-
scription of phoA in each pTAP and pTP transformant
was compared. The levels of phoA mRNA (mean ± SEM)
were determined in pTAP3 (12.49 ± 1.45), pTAP4
(10.89 ± 1.37), pTAP9 (13.41 ± 1.48), pTP1 (1.27 ± 0.05),
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level of phoA transcription in pTAP transformants
(12.09 ± 0.74) was significantly greater (P < 0.05, student’s
t-test) than in pTP transformants (1.55 ± 0.17).
Detection and quantitation of alkaline phosphatase
activity in pTAP and pTP transformants
Five randomly selected pTAP and pTP transformants
were selected and their level of alkaline phosphatase
expression determined. The level of AP activity in un-
transformed cells was used as a baseline. The mean level
(± SEM) of AP activity for 5 pTAP transformants was
190 ± 8 U/mg total cell protein, whilst no AP activity was
detected in pTP transformants and untransformed cells.
Alkaline phosphatase expression localized to the plasma
membrane
Whole cell proteins from pTAP and pTP transformants
were subjected to Western blotting and immunostained30
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Figure 2 Immuno-detection of PhoA in fractionated or trypsin treated
proteins. Proteins of pTAP or pTP transformed cells were separated into hy
transferred and probed with a MAb to alkaline phosphatase. Panel TAP, M.
gallisepticum transformed with pTP cells. Lanes W, whole-cells; H, hydropho
membrane fractions of mycoplasma transformants expressing alkaline phos
gels, Western transferred and immunostained using a MAb to alkaline pho
fraction. C. Surface proteolysis of PhoA. Whole pTAP transformant cells wer
separated on 10 % SDS-polyacrylamide gels, Western transferred and immu
indicated above each lane. Panels CB, Coomassie brilliant blue stained; WB,
VlhA, which was degraded by increasing concentrations of trypsin. The tryp
minimally affected.using a MAb to alkaline phosphatase. Only in those
M. gallisepticum transformed with pTAP, and not in
those transformed with pTP, was an immunoreactive
47 kDa band observed, indicating PhoA expression.
The protein expression of different pTP or pTAP
transformants was similar, and the AP expression of
representative transformants TAP3 and TP1 are shown
in the results.
Whole cell proteins of untransformed, pTP-
transformed or pTAP-transformed M. gallisepticum
were subjected to Triton X-114 fractionation and pro-
teins in the hydrophobic and aqueous fractions were
separated by SDS-PAGE, transferred to PVDF mem-
branes and immunostained using a MAb to alkaline
phosphatase. A band of 47 kDa, corresponding to the
predicted molecular weight of expressed PhoA, was
observed in the pTAP-transformed whole cell proteins
(Figure 2A, TAP, W) and the hydrophobic fraction
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cellular proteins. A. Triton X-114 partitioning of M. gallisepticum cell
drophobic and aqueous fractions by Triton X-114 partitioning, Western
gallisepticum transformed with pTAP and expressing PhoA. Panel A, M.
bic fraction; A, aqueous fraction. B. Immunostaining of cytosolic and
phatase. The fractions were separated on 10 % SDS-polyacrylamide
sphatase. Lanes W, whole cells; M, membrane fraction and C, cytosolic
e treated with increasing concentrations of trypsin, the proteins then
nostained using a MAb to AP. Trypsin concentrations (μg/ml) are
Western blot probed with MAb to AP. The arrow indicates the 67 kDa
tic products of VlhA can also be seen. Most cellular proteins were
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of the fractions from pTP-transformed (Figure 2A, TP,
W, H, A) or untransformed M. gallisepticum cells.
Proteins from M. gallisepticum transformed with
pTAP were separated into membrane and cytosolic frac-
tions by differential ultracentrifugation and the fractions
subjected to SDS-PAGE and Western blotted. Immunos-
taining with a MAb to alkaline phosphatase detected re-
activity in both whole cells (Figure 2B, W) and the
membrane fraction (Figure 2B, M), but not in the cyto-
solic fraction (Figure 2B, C). As a control, MAb 86 [29],
against the VlhA membrane lipoprotein, was also used
to probe the blot and detected VlhA in both whole cell
proteins and in the membrane fraction, but not in the
cytosolic fraction (results not shown).
Trypsin digestion of surface exposed alkaline
phosphatase
The cell surface exposure of M. gallisepticum proteins
and AP were examined by trypsin proteolysis. On the
Coomassie blue stained SDS-PAGE gel, the concentra-
tion of the major cell surface lipoprotein VlhA decreased
with increasing concentrations of trypsin and tryptic
products of this lipoprotein could be seen (Figure 2C,
CB). Immunostaining of trypsin-treated cell proteins
with a MAb to alkaline phosphatase demonstrated a
gradual loss of reactivity with increasing concentrations
of trypsin from 31 μg/ml to 250 μg/ml (Figure 2C, WB),
indicating surface exposure of PhoA. As a control, MAb
86 to VlhA was used to confirm tryptic proteolysis of















Figure 3 Lipoprotein processing of PhoA. A. Effect of globomycin on th
without or with globomycin added, as indicated above each lane, and the
transferred and immunostained using a MAb to AP. In cells grown in globo
a higher molecular weight band was seen, indicative of the presence of th
processed 47 kDa lipoprotein is seen. B. Radiolabelling of PhoA. M. gallisep
radiolabelled with [14 C]palmitate and separated on 10 % SDS-polyacrylami
blue and autoradiographed or Western transferred and immunostained usi
cells. Panels CB, Coomassie brilliant blue stained; WB, Western transferred a
arrow indicates the 67 kDa VlhA protein and the open arrow indicates theshown). The majority of the proteins detectable by Coo-
massie blue staining were not affected by trypsin treat-
ment, indicating that cytoplasmic proteins were not
exposed to proteolysis.Globomycin inhibited PhoA processing
When pTAP transformant cells were grown with in-
creasing concentrations of globomycin, cell growth was
inhibited. A concentration of 25 μg globomycin/ml was
the highest to still allow growth of cells. Growth in
25 μg globomycin/ml resulted in an increase in the mo-
lecular weight of PhoA (Figure 3A, lane 25 μg/ml) com-
pared to that seen in cells grown in the absence of
globomycin (Figure 3A, lane 0 μg/ml).Radiolabelling of lipid modified proteins
Lipoproteins of M. gallisepticum transformed with pTAP
were radiolabelled with [14 C]palmitate, separated by
SDS-PAGE gel and either stained with Coomassie bril-
liant blue (Figure 3B, CB) and autoradiographed
(Figure 3B, RL) or Western transferred and immunos-
tained (Figure 3B, WB). Following autoradiography, a
band of 47 kDa, similar to the expected size of alkaline
phosphatase, was detected in the pTAP transformed
cells (Figure 3B, RL, 2), suggesting that PhoA in pTAP
transformed M. gallisepticum was a lipoprotein. A West-
ern blot immunostained with a MAb to AP demon-
strated the presence of a recombinant AP protein of
similar size to that of the radiolabelled band in pTAP-
transformed M. gallisepticum (Figure 3B, WB, 2).CB                     WB
1 2 1 2 1 2
RL
e processing of PhoA. Mycoplasma transformants were grown in broth
ir proteins separated on 10 % SDS-polyacrylamide gels, Western
mycin (25 μg/ml), and thus in which signal peptidase II was inhibited,
e prolipoprotein. In the absence of globomycin (0 μg/ml) the fully
ticum cell proteins and pTAP transformed M. gallisepticum cells were
de gels. The polyacrylamide gels were stained with Coomassie brilliant
ng a MAb to AP. Lanes 1, M. gallisepticum cells; 2, pTAP transformed
nd immunostained; RL, radiolabelled and autoradiographed. The dark
47 kDa protein.
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spectrometric analysis of PhoA proteins
Following separation of Triton X-114 preparations of
protein by 2-D gel electrophoresis, a spot corresponding
to PhoA was excised, digested with trypsin and analysed
by mass spectrometry. Peptide mass fingerprinting
resulted in the positive identification of PhoA, with a
Mascot score of 191 and sequence coverage of 53 %
(Figure 4). Potential (unmodified) amino-terminal tryptic
peptides (MKRKNILKFISLLGIGSFVMLAAASCTTPV-
LENR, CTTPVLENR or SCTTPVLENR) were not iden-
tified. Attempts to recover the acylated peptide in
organic extracts of the gel spot were also unsuccessful.
Discussion
In this study we used the transposon Tn4001-based vec-
tor pISM2062.2lac, modified to form pISM2062.2ltufa-
cyphoA, to transform M. gallisepticum and express
functional alkaline phosphatase on the cell surface. Two
constructs containing the alkaline phosphatase gene, one
with the vlhA1.1 leader and acylation sequences and an-
other without these sequences, were introduced into the
Tn4001 transposon arm. Following transformation and
immunoblotting, a 47 kDa protein was detected in con-
structs containing the vlhA1.1 leader and acylation se-
quence. The vlhA acylation sequence was chosen with
the purpose of expressing the recombinant protein as a
lipoprotein.
To confirm the processing of PhoA as a lipoprotein,


















Figure 4 Identification of PhoA by mass spectrometry. A tryptic digest
mass fingerprint’ that was subsequently searched against the NCBI databas
sequences. The sequence shown is PhoA, and the matched peptides are u
matched peptides are shown in the table below.cells were carried out. In M. gallisepticum, lipoproteins
are predicted to be processed by signal peptidase II, as
no other protein processing pathways are known to be
present. Processing of lipoproteins by signal peptidase II
is specifically inhibited by globomycin and, consequently,
processing into a mature lipopeptide is reduced. The
increased size of PhoA in cells grown in the presence of
globomycin suggests that the VlhA signal sequence was
not processed, resulting in an unacylated preprotein.
Metabolic labelling of mycoplasmas can be problematic
because of the requirement for serum in media, which
results in low incorporation of lipids in radiolabelled
cells [30]. The presence of other lipoproteins of similar
molecular weight that can be labelled with palmitic acid
[31] can interfere with specific detection of radiolabelled
proteins in SDS-PAGE gels. While it potentially offers
greater specificity, detection in 2-D gels was problematic
because of the low efficiency of label incorporation, the
low abundance of PhoA and the limited loading capacity
of 2-D gels, which are likely to have contributed to our
inability to detect radiolabelled PhoA after 2-D gel
electrophoresis.
Alkaline phosphatase activity was not detected in TP
transformants. AP of E. coli has two identical subunits,
which fold as monomers and then form dimers for en-
zymatic activity. In E. coli, the proteins thioredoxin re-
ductase (TrxB) and thio-disulfide isomerase (Dsb)
maintain the reduced state during export of the protein
across the cytoplasmic membrane [32]. It is translocated

















of the 2-D gel spot was analysed by MALDI-TOF to obtain a ‘peptide
e (Taxonomy= Bacteria). The only significant matches were to AP
nderlined. The predicted signal peptide is double underlined. The 16
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leader peptide is cleaved and the mature alkaline phos-
phatase is released into the periplasm [33]. Homologous
proteins must have been present to enable the folding
and export of functional PhoA in pTAP-transformed M.
gallisepticum. The absence of detectable alkaline phos-
phatase expression and activity in pTP-transformed
mycoplasma cells could be attributable to the lower level
of transcription of phoA together with the possible re-
tention of the protein in the cytoplasm in a reduced
form, and thus inactive, and subsequent proteolysis.
Since the promoter region and all other sequences pre-
ceding the start codon were identical to those in pTAP,
similar levels of transcription were expected for both
constructs, but there was an eight-fold lower level of
phoA in pTP transformed cells compared to in those
transformed with pTAP. It is not clear whether the sig-
nal sequence in the pTAP construct could have affected
transcription and further studies are needed to elucidate
the mechanisms for the lack of PhoA activity in pTP
transformants.
Generally the differences in the protein export path-
way of Gram-positive bacteria result in low phoA activity
when it is introduced into these organisms [34]. This
has led to the use of the Enterococcus faecalis-derived
phoZ as a reporter system in Gram-positive bacteria
[35]. Although mycoplasmas have similarities to Gram-
positive bacteria, this study has shown that phoA from
E. coli can be expressed as a membrane protein in M.
gallisepticum.
As the construct could be successfully introduced into
M. galliseptcium using the transposon Tn4001, it could
provide a suitable model for investigating membrane
protein export in other mycoplasma species. Other
workers have investigated the use of TnphoA to detect
membrane protein export signal sequences from gen-
omic libraries of mycoplasmas, after introduction into E.
coli [13,36]. The pTAP vector will be a valuable and ver-
satile tool for studies analysing regulatory effects of pro-
moter regions, gene expression using different
translational start codons and leader sequences and also
for optimising expression of foreign antigens. Studies on
gene regulation could also be facilitated by using the
PhoA vector.
Mycoplasma lipoproteins are surface exposed and have
atypical acylation, and are commonly immunodominant.
Thus expression of an antigen as a lipoprotein is likely
to be an optimal approach to inducing a vaccinal re-
sponse [37]. Heterologous lipoprotein expression has
been demonstrated in mycoplasmas and its use as live
vaccine was emphasized in Mycoplasma capricolum
subsp. capricolum, in which spiralin has been expressed
on the cell surface using an oriC plasmid vector [38].
The phoA vector we have described here could be usedto facilitate optimisation of expression of heterologous
bacterial or viral antigens, and immunomodulators on
the mycoplasma cell surface. Preliminary studies in our
laboratory using the phoA vector have been successful in
expressing the immunomodulatory genes of chicken
IFN-γ in the ts-11 vaccine strain [39]. The expression of
such immunomodulatory genes has the potential to en-
hance the immunogenicity of live attenuated vaccines by
intrinsic adjuvantation. The phoA expression system
allows rapid assessment of the level of expression from
different promoter and signal sequences and thus opti-
misation of both expression and translocation of such
heterologous proteins.
Conclusions
This is the first study to express alkaline phosphatase on
the mycoplasma cell surface. The use of this system will
enable us to further study protein translocation across
mycoplasma membranes. The study also demonstrates
the ease of using phoA as a reporter gene in mycoplas-
mas. Thus, we have successfully developed a vector sys-
tem in mycoplasmas with the potential for use in
optimising heterologous gene expression and ultimately
in recombinant vaccine development, in addition to its
potential as used as a tool in studies of the molecular
pathogenesis of mycoplasmosis.
Methods
Bacterial strains and culture conditions
M. gallisepticum strain S6 was grown in mycoplasma
broth (MB) or on mycoplasma agar (MA; containing 1 %
agar (Oxoid) without phenol red) at 37 °C [29]. For se-
lection of mycoplasma transformants, 16 μg of gentami-
cin/ml (Invitrogen) was added to the media.
E. coli DH5α cells were used as the host for genetic
manipulation and cloning of plasmids. Clones were
grown in Luria-Bertani broth (LB) or on LB agar plates
(LB with 1 % agar) containing 100 μg ampicillin/ml
(Amresco) at 37 °C. For detection of alkaline phosphat-
ase activity in transformants grown on solid media, the
substrate 5-bromo-4-chloro-3-indolyl phosphate (BCIP)
(Sigma) was added to the LB agar plates or MA to a final
concentration of 40 μg/ml.
Amplification of DNA sequences by PCR
PCR was carried out using Platinum HiFi Taq DNA
polymerase (Invitrogen) in a 25 μl volume containing
2.5 μl of 10 x buffer (Invitrogen), 2 mM MgSO4, 100 μM
of each deoxynucleotide triphosphate (Bioline), 0.4 μM
of each primer, 1.5 U of enzyme and 5 ng of each PCR
product as template. The reaction was performed in an
iCycler (BioRad) with an initial cycle of 95 °C for 3 min,
followed by 35 cycles of 94 °C for 30 s, 60 °C for 30 s
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for 7 min.
Development of alkaline phosphatase construct
The E. coli phoA gene lacking a promoter, signal se-
quence and the first 5 residues of the mature protein
[28] was cloned under the control of the ltuf promoter
and fused to the lipoprotein acylation signal sequence of
vlhA1.1, and subsequently cloned into the Tn4001 trans-
poson contained in pISM2062.2 to generate the plasmid,
pISM2062.2ltufacyphoA (pTAP) (Figure 1A). Another
plasmid (pTP), lacking the signal and acylation sequence
(pTP), was also produced (Figure 1B).
The pTAP and pTP constructs were introduced into
E. coli DH5α by electroporation using a Gene Pulser
(BioRad) with settings of 2.5 kV and 25 μF. Recombi-
nants were selected for ampicillin resistance and clones
were screened for the presence of the gentamicin re-
sistance gene using the oligonucleotide primers GmF
and GmR. Selected clones were cultured in larger
volumes and plasmid DNA extracted using a Midi
prep kit (Qiagen) according to the manufacturer’s
instructions.
Transformation of M. gallisepticum
M. gallisepticum was transformed by electroporation as
described previously [39,40]. Following electroporation,
cells were gently resuspended in 1 ml of ice-cold MB,
incubated at 37 °C to allow expression of the gentamicin
resistance gene, then a 500 μl aliquot of the culture
inoculated onto MA plates containing 16 μg of gentami-
cin/ml, which were allowed to dry and then incubated at
37 °C for 4 days. The plates were examined for colony
development and single colonies selected and subcul-
tured in MB containing 16 μg of gentamicin/ml.
Detection of alkaline phosphatase activity on MA plates
To detect alkaline phosphatase activity in colonies of
transformed M. gallisepticum on MA plates, a single
tablet of BCIP/nitroblue tetrazolium (NBT) (Sigma Fast,
Sigma) was dissolved in 3 ml distilled water and sprayed
onto the colonies uniformly as a thin layer using a pump
atomizer. After 10 min colonies were observed for the
presence of a blue colour.
Genomic DNA sequencing
To determine the insertion site of the transposon, gen-
omic DNA sequencing was carried out using the ABI
Prism BigDye Terminator v3.1 (BDT) sequencing sys-
tem (Perkin Elmer Applied Biosystems) and the UBR
oligonucleotide primer (Table 1) according to the man-
ufacturer's instructions, with minor modifications. Ap-
proximately 2 μg of genomic DNA was combined with
1 μM of the UBR oligonucleotide, 4 μl of the BDTenzyme mixture, 4 μl of 5 x BDT buffer and distilled
water to 20 μl. The sequencing reaction mixture was
incubated at 96 °C for 5 min, then through 60 cycles
of 96 °C for 30 s, 50 °C for 10 s and 60 °C for 4 min
in an iCycler thermocycler (BioRad). The sequencing
products were purified according to the manufacturer’s
instructions using ethanol-EDTA-sodium acetate pre-
cipitation and analysed using an ABI3100 capillary
sequencer.
Quantitative RT-PCR
Quantitative RT-PCR (qRT-PCR) was used to determine
the level of transcription of the phoA gene in each of the
transformants. To achieve this, total RNA from 6 ml of
transformant cells was extracted using an RNA purifica-
tion kit (Qiagen), following the manufacturer’s instruc-
tions. The total amount of RNA was determined using
an ND-1000 spectrophotometer (NanoDrop). To remove
any contaminating DNA, 2 μg of extracted RNA was
treated with 2 U of DNase I (Invitrogen) in a buffer con-
taining 2 μl of 10 x DNase I buffer and RNase-free water
in a total volume of 20 μl for 15 min at room
temperature. To produce cDNA, 1 μg of DNAse I-
treated RNA was used. For each 1 μg of DNAse I-
treated RNA, 50 ng of random hexamers (Invitrogen)
and 10 nM of each deoxynucleoside triphosphate
(dNTPs, Bioline) were added and the mixture incubated
at 65 °C for 5 min, then immediately cooled on ice. To
this, 4 μl of 5 x first strand reaction buffer (Invitrogen)
and dithiothreitol (Invitrogen) to a final concentration of
0.1 M were added and the mixture incubated at 25 °C
for 2 min, then 1 μl (200 U) of Superscript II reverse
transcriptase (RT) (Invitrogen) was added and the reac-
tion incubated for 10 min. A negative control (no RT)
was also included, with 1 μl of RNase-free water substi-
tuted for the Superscript II reverse transcriptase. The re-
verse transcription reactions were incubated at 42 °C for
50 min. The reaction was stopped by incubation at 70 °C
for 15 min and the total volume made up to 600 μl with
nuclease-free water and aliquots stored at −20 °C. Each
qRT-PCR reaction was conducted in a 20 μl volume and
contained 5 μl template cDNA, 10 μl of 2 x Platinum
SYBR Green qPCR Supermix containing Rox Dye (Invi-
trogen) and 100 nM each of the PRTF and PRTR pri-
mers (Table 1). Reactions were run using a Stratagene
MX3000P. Each assay included test cDNA, the no-RT
control reaction previously described and a no template
control, to which only water was added. The cycling
conditions were an initial incubation for 2 min at 50 °C,
followed by 5 min at 95 °C, then 40 cycles of 95 °C for
30 s and 60 °C for 30 s. Reactions were carried out in
triplicate for each sample. Relative quantification of
phoA transcription was normalised against transcription
from the glyceraldehyde 3-phosphate dehydrogenase
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HMR primers (Table 1) and the relative level of expres-
sion calculated using the delta-delta Ct method [41].
Detection of alkaline phosphatase activity in cultured
cells
Mycoplasma transformants were grown in 10 ml MB
supplemented with gentamicin at 16 μg/ml until an ap-
proximate pH of 7.2 was reached, then pelleted by cen-
trifugation at 20,000 x g for 20 min at 4 °C. The cells
were resuspended and washed twice in ice-cold 0.05 M
Tris, pH 8.0 (T buffer) and again centrifuged and
washed as before. The cells were finally resuspended in
T buffer with 1 % Triton X-100 (ICN) added and incu-
bated for 15 min at 4 °C. The total protein concentration
of the cell lysate was determined in triplicate using a
BCA kit (Pierce) following the manufacturer’s instruc-
tions. To determine the AP activity of each transformant
in triplicate, 10 μl of the cell lysate was added to reaction
buffer (1 M Tris, pH 8.0, 1 mM MgCl2) to which 50 μl
of 2 mM disodium p-nitrophenyl phosphate (pNPP, Cal-
biochem) in reaction buffer was added and the mixture
incubated at 37 °C for 30 min. The reaction was termi-
nated by addition of 100 μl 2 M NaOH and the absorb-
ance read at 410 nm using a spectrophotometer
(Labsystems Multiskan MS). In each assay doubling dilu-
tions in triplicate, starting at 12 U of bacterial alkaline
phosphatase (BAP, Invitrogen), were made in T buffer
and similarly treated, enabling a standard curve to be
constructed. The alkaline phosphatase activity in the
BAP dilution series was plotted against absorbance and
this used to determine the alkaline phosphatase activity
in each sample, which was expressed as BAP U/mg of
total cell protein.
SDS-PAGE, Western blotting and immunostaining
Mycoplasma cell proteins were separated by SDS-PAGE
as described previously [42]. The protein concentrations
of mycoplasma cells were determined using the Pierce
BCA protein assay kit (Thermo Scientific), using bovine
serum albumin as the standard, and 10 μg of total cell
protein was loaded into each well of a polyacrylamide
gel. After separation in a 10 % polyacrylamide gel, pro-
teins were transferred onto PVDF membranes and incu-
bated in blocking solution containing 5 % (w/v) skim
milk (Devondale) in PBS with 0.1 % (v/v) Tween 20
(PBS-T) for 2 h at room temperature on a rocking plat-
form. Following blocking, membranes were washed
three times for 5 min each in PBS-T. Membranes were
then incubated for 1 h with mouse monoclonal antibody
(MAb) to alkaline phosphatase (Chemicon) at a 1:5000
dilution in blocking solution. The membranes were
washed thrice for 5 min with PBS-T and incubated with
rabbit anti-mouse-horseradish peroxidase (HRPO)conjugate (Dako) for 1 h at a 1:5000 dilution in blocking
solution. This was followed by washing thrice for 5 min
each with PBS-T and bound conjugate was then detected
by chemiluminiscence using an ECL Plus kit (GE
Healthcare) according to the manufacturer's recommen-
dations. As molecular weight marker, 10 μl of biotiny-
lated protein ladder (Cell Signaling Technology) was
loaded, and for detection in Western blots, HRP-linked
anti-biotin antibody was used.Partitioning of mycoplasma cell proteins into
hydrophobic and aqueous fractions using Triton X-114
Mycoplasma cell proteins from a 20 ml overnight cul-
ture were separated into hydrophobic and aqueous frac-
tions using the detergent Triton X-114 (Sigma) [43,44].
The urea solubilised protein fractions were then ana-
lysed by SDS-PAGE.Membrane and cytoplasmic separation
Membrane and cytoplasmic fractions of M. gallisepticum
were purified essentially as previously described for M.
pneumoniae [45]. The cytosolic and membrane fractions
were then analysed by SDS-PAGE and immunoblotting.Trypsin treatment of intact M. gallisepticum transformant
cells
M. gallisepticum cells were cultured and the cell pellet
washed in 50 mM Tris, 0.145 M NaCl, pH 7.4 (TS buf-
fer). This was repeated twice and the cells finally resus-
pended in 600 μl TS buffer, then divided into 6 equal
aliquots. A dilution series of trypsin (Sigma) at 250, 125,
62, 31 and 15 μg/ml was made in TS buffer and 100 μl
of each dilution, as well as a control without any trypsin,
added to a separate aliquot of cells and these incubated
at 37 °C for 30 min. Digestion was stopped by the
addition of 200 μl of 0.125 % (w/v) trypsin inhibitor
(Sigma). The trypsin-treated cells were collected by cen-
trifugation, resuspended in TS buffer and proteins in the
sample separated by SDS-PAGE and either stained with
Coomassie brilliant blue or immunoblotted.Globomycin treatment
Globomycin is a peptide antibiotic that inhibits the pro-
cessing of prolipoprotein to mature lipoprotein by signal
peptidase II [46,47]. Mycoplasma cells were grown in
the presence or absence of globomycin (a gift from Dr.
M. Inukai, IUHW, Japan), dissolved in methanol. Cells
were grown in MB with 25 μg globomycin/ml and the
cells were harvested by centrifugation at 20,000 x g for
20 min at 4 °C, washed thrice in PBS and proteins in the
sample separated by SDS-PAGE and either stained with
Coomassie brilliant blue or immunoblotted.
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M. gallisepticum transformants were cultured in
20 ml MB to pH 7.2 and cells harvested and resus-
pended in 2 ml of fresh MB containing 10 μCi [14 C]
palmitate/ml (Perkin Elmer), then incubated at 37 °C
for 18 h. The cells were centrifuged at 8000 g for
20 min at 4 °C and washed in 2 ml PBS. The washing
step was repeated three times. The cells were resus-
pended in 100 μl PBS and SDS-PAGE lysis buffer added.
Mycoplasma proteins, together with [14 C] methylated
molecular weight markers (Sigma), were separated by
SDS-PAGE in a 10 % polyacrylamide gel and fixed in
a solution of 10 % (v/v) glacial acetic acid and 30 %
(v/v) methanol for 30 min. The gel was incubated in
EN3HANCE (Life Science Products) according to the
manufacturer's instructions, vacuum dried and then
exposed to X-ray film (Kodak).
Two-dimensional gel electrophoresis of fractionated
mycoplasma cell proteins
M. gallisepticum cells were harvested and fractionated
with Triton X-114 as described above, and the hydro-
phobic fraction was resuspended in 8 M urea, 2 %
CHAPS, 0.5 % IPG buffer (3–10) and 18 mM dithio-
threitol (DTT, GE Healthcare). A 125–150 μg sample of
protein, as estimated using the 2-D-Quant kit (Amer-
sham Biosciences), was subjected to isoelectric focusing
(IEF) on 7 cm strips over the pH range of 3–10 (GE
Healthcare) using the following parameters: rehydration
at 30 V for 6 h, 60 V for 6 h; running at 200 V for 1 h,
500 V for 1 h, 1000 V for 1 h, 1000–8000 V for 1 h and
8000 V for 1.5 h. After isoelectric focusing the gel strips
were equilibrated twice in 6 M urea, 75 mM Tris–HCl,
pH 8.8, 2 % SDS and 30 % glycerol (65 mM DTT,
0.135 M iodoacetamide) for 15 min each. Immediately
following equilibration and fixing, the IEF strips were
transferred onto a 10 % SDS-polyacrylamide gel and
fixed in place with 0.5 % agarose containing bromophe-
nol blue. Electrophoresis was carried out at 200 V for
1 h. The gels were stained with Coomassie brilliant blue.
Mass spectrometry of PhoA
Following 2-D gel electrophoresis of fractionated cellu-
lar proteins of untransformed and TAP- transformed
M. gallisepticum, the gel images were compared in
order to locate the gel spot likely to correspond to
PhoA. This spot was excised and subjected to in-gel
digestion and peptide mass fingerprint analysis as
described previously [48] using an Ultraflex III MALDI
TOF/TOF instrument (Bruker Daltonics, Bremen).
Spectra were acquired in reflectron mode and cali-
brated externally using a standard peptide mix (Bruker
Daltonics). Proteins were identified using Mascot v 2.2
(Matrix Science) with the following search parameters:database =NCBI, taxonomy = bacteria, enzyme= trypsin,
mass tolerance = 30 ppm, missed cleavages = 1, fixed
modifications = carbamidomethyl (Cys) and optional
modifications = oxidation (Met).
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